Skip to main content

Animations

MJFF Publications

4771 - 4780 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Gastric acid suppressants and cognitive decline in people with or without cognitive impairment
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/trc2.12243
    Citation Count: 11
  • Summary Details
    OPEN
    Title: A novel process driving Alzheimer's disease validated in a mouse model: Therapeutic potential
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/trc2.12274
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core study
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/trc2.12329
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Tracking cortical excitability dynamics with transcranial magnetic stimulation in focal epilepsy
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51535
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Plasma phosphorylated tau181 predicts cognitive and functional decline
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51695
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Late Breaking Orals
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/jev2.12252
    Citation Count: 0
  • Summary Details
    OPEN
    Title: mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double‐Blind, Placebo‐Controlled Futility Trial and 1‐Year Biomarker Longitudinal Analysis
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28923
    Citation Count: 23
  • Summary Details
    RESTRICTED
    Title: Suitability of Automated Writing Measures for Clinical Trial Outcome in Writer's Cramp
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29237
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Density of Patient-Sharing Networks: Impact on the Value of Parkinson Care
    Journal Name: International Journal of Health Policy and Management
    Publisher: Maad Rayan Publishing Company
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.34172/ijhpm.2021.15
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Predictors of Spiritual Well-Being in Family Caregivers for Individuals with Parkinson's Disease
    Journal Name: Journal of Palliative Medicine
    Publisher: Mary Ann Liebert Inc
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1089/jpm.2020.0797
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.